These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9873062)

  • 1. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
    J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis.
    Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC
    Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
    Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
    Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
    Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
    Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J; Grundy M; Shang S; Russell N; Pallis M
    Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.
    Gupta V; Bhinge KN; Hosain SB; Xiong K; Gu X; Shi R; Ho MY; Khoo KH; Li SC; Li YT; Ambudkar SV; Jazwinski SM; Liu YY
    J Biol Chem; 2012 Oct; 287(44):37195-205. PubMed ID: 22936806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
    Liu YY; Hill RA; Li YT
    Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.
    Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T
    FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.
    Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G
    J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
    Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
    Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
    Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW
    Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
    Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
    Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):541-6. PubMed ID: 10427137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for ceramide in driving cancer cell resistance to doxorubicin.
    Liu YY; Yu JY; Yin D; Patwardhan GA; Gupta V; Hirabayashi Y; Holleran WM; Giuliano AE; Jazwinski SM; Gouaze-Andersson V; Consoli DP; Cabot MC
    FASEB J; 2008 Jul; 22(7):2541-51. PubMed ID: 18245173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.